Diagnostic value of eosinophils in pleural effusion: A prospective study of 26 cases

Diagnostic Cytopathology

Volumn 28, Issue 2, 2003, Pages 96-99

  Matthai, Smita Mary ^a   Kini, Usha ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Eosinophilia; Pleural effusion; Prognosis; Thoracentesis

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL TRIAL; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENDEMIC DISEASE; EOSINOPHIL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIA; INFLAMMATION; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; THORACOCENTESIS; TUMOR DIAGNOSIS;

CELL COUNT; EOSINOPHILIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0037308426     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10227     Document Type: Article

References (16)

1. Light RW. Clinical manifestation and useful tests. In: Pleural diseases, 4th ed. Baltimore: Williams & Wilkins; 2001. p 48-50.
2. Hirsch A, Ruftic P, Nebut M, et al. Pleural effusion: laboratory tests in 300 cases. Thorax 1979;34:106-112.
3. Fraser RG, Muller NL, Colman N, Pare PD. Biochemical findings in pleural effusion. In: Fraser RG, Pare PD, editors. Diagnosis of the diseases of the chest, 4th ed., vol 4. Philadelphia: W.B. Saunders; 1999. p 2741-2742.
4. Paramathayan NS, Barron J. New criteria for the differentiation between transudates and exudates. J Clin Pathol 2002;55:69-71.
5. Chapman JS. Effect of solvents on eosinophil stimulating substance of erythrocyte stroma. Proc Soc Exp Biol Med 1961;108:566-569.
6. Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. Chest 1996;110:1271-1274.
7. Archer R. The eosinophil leukocytes. Philadelphia: FA Davis; 1963. p 14.
8. Laster CE, Gleich GJ. Chemotaxis of eosinophils and neutrophils by aggregated immunoglobulins. J Allergy Clin Immunol 1971;48:297-304.
9. Cohen S, Ward PA. In vitro and in vivo activity of a lymphocyte and immune complex dependent chemotactic factor for eosinophils. J Exp Med 1971;133:133-146.
10. Schandene L, Namias B, Crusiaux A, et al. IL-5 in posttraumatic eosinophilic pleural effusion. Clin Exp Immunol 1993;93:115-119.
11. Riantawan P, Bangpattnasiri K, Chaowalit P, Sangsayan P. Etiology and clinical implications of eosinophilic pleural effusions. Southeast Asian J Trop Med Public Health 1998;29:655-659.
12. Bassiri AG, Morris W, Kirsch CM. Eosinophilic tuberculous pleural effusion. West J Med 1997;166:277-279.
13. Veress JF, Koss LG, Schreiber K. Eosinophilic pleural effusion. Acta Cytol 1979;23:40-44.
14. Leff A, Hopewell PC, Costello J. Pleural effusion from malignancy. Ann Intern Med 1978;88:532-537.
15. Martinez-Garcia MA, Cares-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000;15:166-169.
16. Curran WS, Williams AW. Eosinophilic pleural effusion: a clue in differential diagnosis. Arch Intern Med 1963;3:809-813.